United States[Member] was CollPlant Biotechnologies’s largest region in fiscal 2025, bringing in $2.18M of $2.37M (92%).
| Geography | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| United States[Member] | — | $10.84M | $484.00K | $2.18M | ||||
| United States | $16.00K | — | — | — | ||||
| United States & Canada | — | — | — | — | ||||
| Total | — | — | — | — | ||||
| Europe & Israel | — | — | — | — | ||||
| Europe | — | — | — | — | ||||
| Europe & Other | $104.00K | $28.00K | — | $98.00K | ||||
| Canada | $158.00K | $87.00K | — | $96.00K | ||||
| Israel | $21.00K | $5.00K | $31.00K | $1.00K | ||||
| Total | $299.00K | $10.96M | $515.00K | $2.37M |
CollPlant Biotechnologies brought in $2.37M from its four regions in fiscal 2025, the year ended December 31, 2025. CollPlant Biotechnologies regrouped these regions after fiscal 2024, so the total does not compare directly with that year's $515.00K. United States[Member] was the largest at $2.18M (91.8%), ahead of Europe & Other at $98.00K (4.1%) and Canada at $96.00K (4.0%). The remaining region, Israel, brought in $1.00K.
CollPlant Biotechnologies began breaking out United States[Member] in fiscal 2023, when it brought in $10.84M. CollPlant Biotechnologies stopped reporting United States as a separate region after fiscal 2022, when it brought in $16.00K.
United States & Canada was CollPlant Biotechnologies’s largest region in fiscal 2018, bringing in $17.51M of $18.03M (97%).
| Geography | FY 2017 | FY 2018 |
|---|---|---|
| United States & Canada | $802.00K | $17.51M |
| Europe Country | $866.00K | $523.00K |
| Total | $1.67M | $18.03M |
CollPlant Biotechnologies brought in $18.03M from its two regions in fiscal 2018, the year ended December 31, 2018. That was up 981.2% from $1.67M in fiscal 2017. United States & Canada was the largest at $17.51M (97.1%), ahead of Europe Country at $523.00K (2.9%).
Compared with fiscal 2017, United States & Canada grew 2,083.4% to $17.51M, while Europe Country fell 39.6% to $523.00K.
CollPlant Biotechnologies (CLGN) reports its revenue by geography. In fiscal 2025, United States[Member] was its largest region, bringing in $2.18M (91.8% of the total), followed by Europe & Other at $98.00K (4.1%).
United States[Member] was CollPlant Biotechnologies' largest region in fiscal 2025, bringing in $2.18M, or 91.8% of the $2.37M total across its four regions.
United States & Canada grew faster than Europe Country in fiscal 2018, up 2,083.4% from $802.00K to $17.51M. Europe Country fell 39.6% to $523.00K.
Every figure comes from CollPlant Biotechnologies' annual financial filings, as reported. Each line keeps the name CollPlant Biotechnologies gives it, and years follow its fiscal calendar.
CollPlant Biotechnologies' revenue by geography goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.